|Institutional Source||Beutler Lab|
|Gene Name||dynein, axonemal, heavy chain 5|
|Synonyms||b2b1565Clo, b2b1134Clo, Mdnah5, b2b1537Clo, b2b1154Clo, Dnahc5|
NCBI RefSeq: NM_133365.3; MGI: 107718
|Essential gene?||Possibly essential (E-score: 0.682)|
|Stock #||R7350 (G1)|
|Chromosomal Location||28203752-28472052 bp(+) (GRCm38)|
|Type of Mutation||critical splice donor site (2 bp from exon)|
|DNA Base Change (assembly)||T to A at 28235819 bp (GRCm38)|
|Amino Acid Change|
|Ref Sequence||ENSEMBL: ENSMUSP00000069751 (fasta)|
|Gene Model||predicted gene model for transcript(s): [ENSMUST00000067048]|
|AlphaFold||no structure available at present|
|Coding Region Coverage||
FUNCTION: [Summary is not available for the mouse gene. This summary is for the human ortholog.] This gene encodes a dynein protein, which is part of a microtubule-associated motor protein complex consisting of heavy, light, and intermediate chains. This protein is an axonemal heavy chain dynein. It functions as a force-generating protein with ATPase activity, whereby the release of ADP is thought to produce the force-producing power stroke. Mutations in this gene cause primary ciliary dyskinesia type 3, as well as Kartagener syndrome, which are both diseases due to ciliary defects. [provided by RefSeq, Oct 2009]
PHENOTYPE: Mice homozygous for a disruption in this gene display postnatal lethality, hydrocephalus, respiratory infections, situs inversus and ciliary immotility. [provided by MGI curators]
|Allele List at MGI||
All alleles(11) : Targeted(2) Gene trapped(1) Transgenic(1) Chemically induced(7)
|Other mutations in this stock||
|Other mutations in Dnah5||
(F):5'- GCTCTTATTTTGCAATCATCTGGG -3'
(R):5'- GGCTTCAACATTGAGTGAGAAATG -3'
(F):5'- TGCAATCATCTGGGATAAGTGC -3'
(R):5'- TTGAGTGAGAAATGTAAGGCAATTC -3'